US Broker Ratings

Krystal Biotech, Inc. (KRYS) Stock Analysis: A 49.7% Potential Upside in the Biotech Sector

Krystal Biotech, Inc. (NASDAQ: KRYS), a prominent player in the biotechnology sector, presents a compelling case for investors seeking opportunities in the healthcare industry. With its..

Blueprint Medicines Corporation (BPMC) Stock Analysis: Navigating the Precision Therapy Market with a 55.5% Revenue Growth

Blueprint Medicines Corporation (NASDAQ: BPMC), a prominent player in the biotechnology sector, specializes in developing targeted therapies for genomically defined cancers and blood disorders. With a..

Repligen Corporation (RGEN) Stock Analysis: Unveiling a 43.70% Potential Upside in the Bioprocessing Market

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector specializing in medical instruments and supplies, continues to capture investor attention with its innovative solutions..

Exelixis, Inc. (EXEL) Stock Analysis: Navigating Growth in Oncology with a 30.60% Revenue Surge

Exelixis, Inc. (NASDAQ: EXEL), a leading player in the biotechnology sector, is making waves with its robust focus on oncology. As a United States-based company, Exelixis..

Oscar Health, Inc. (OSCR) Stock Analysis: Promising 33% Upside with Strong Revenue Growth

Oscar Health, Inc. (NYSE: OSCR) stands out in the healthcare sector, particularly in the healthcare plans industry, as a company with significant growth potential. With a..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Exploring the 70% Upside Potential

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is capturing the attention of savvy investors with its promising pipeline and a significant upside potential of 70.08%. This biopharmaceutical company,..

Legend Biotech Corporation (LEGN) Investor Outlook: A 107% Potential Upside Amidst Robust Revenue Growth

Legend Biotech Corporation (NASDAQ: LEGN), a pioneering entity in the field of biotechnology, has captured the attention of investors with its impressive revenue growth and promising..

Nuvalent, Inc. (NUVL) Stock Analysis: Uncovering a 43.72% Potential Upside in Biotech Innovation

Nuvalent, Inc. (NASDAQ: NUVL) is making waves in the biotechnology sector, offering a compelling investment opportunity with a significant potential upside of 43.72%. This clinical-stage biopharmaceutical..

BioNTech SE (BNTX) Stock Analysis: Evaluating a 27.49% Potential Upside in the Biotech Arena

BioNTech SE (NASDAQ: BNTX) presents an intriguing investment opportunity for those with a keen interest in the biotechnology sector. Known for its groundbreaking work in immunotherapies..

Waystar Holding Corp. (WAY) Stock Analysis: 24% Potential Upside Beckons Investors

Waystar Holding Corp. (NASDAQ: WAY) is capturing the attention of investors with its solid position in the healthcare sector, particularly in the health information services industry...

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Unraveling a 133.80% Potential Upside in the Biotechnology Sector

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a prominent player in the biotechnology sector, commands attention with a substantial market capitalization of $3.56 billion. Specializing in RNA-targeted therapeutics..

Encompass Health Corporation (EHC): Stock Analysis Reveals 8.82% Upside Potential for Strategic Investors

Encompass Health Corporation (NYSE: EHC), a prominent player in the healthcare sector, is capturing the attention of savvy investors with its impressive stock performance and promising..

iRhythm Technologies (IRTC) Stock Analysis: Healthcare Innovator with Strong Buy Ratings Amidst Valuation Challenges

Investors navigating the healthcare sector’s dynamic landscape may find iRhythm Technologies, Inc. (NASDAQ: IRTC) an intriguing prospect. With a current market capitalization of $4.59 billion, iRhythm..

Glaukos Corporation (GKOS) Investor Outlook: Analyzing 25% Potential Upside Amid Strong Buy Ratings

Glaukos Corporation (NYSE: GKOS), a leader in ophthalmic pharmaceuticals and medical devices, is catching the eye of investors with its promising growth potential. The company, headquartered..

Takeda Pharmaceutical (TAK) Stock Analysis: Exploring a 12.61% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a prominent player in the healthcare sector, stands out in the drug manufacturing industry with its strong global presence and..

Insmed Incorporated (INSM) Stock Analysis: A Biotech Powerhouse with 11.48% Upside Potential

For investors keen on the biotechnology sector, Insmed Incorporated (INSM) offers an intriguing opportunity. With a robust market cap of $18.75 billion and an impressive array..

Labcorp Holdings Inc. (LH) Investor Outlook: Analyzing Growth Potential and Market Position

Labcorp Holdings Inc. (NYSE: LH) stands out as a key player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization..

TG Therapeutics, Inc. (TGTX): Analyst Consensus and Growth Potential in the Booming Biotech Sector

TG Therapeutics, Inc. (NASDAQ: TGTX) has emerged as a noteworthy player in the biotechnology landscape, boasting a market capitalization of $5.72 billion. This North Carolina-based biopharmaceutical..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Unlocking 24% Potential Upside with Biotech Innovation

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is making waves in the biotechnology sector, drawing attention from investors with its innovative approach to drug delivery and a promising..

Ascendis Pharma A/S (ASND) Stock Analysis: Exploring a 33.89% Potential Upside in Biotech Innovation

Ascendis Pharma A/S (NASDAQ: ASND), a Danish biopharmaceutical innovator, is capturing investor attention with its promising growth potential and cutting-edge therapeutic developments. Operating in the dynamic..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds